Verastem Oncology Competitors and Similar CompaniesClear all

Verastem Oncology's competitors and similar companies include Tanvex BioPharma, Novartis, Relay Therapeutics, Mirati Therapeutics and InxMed.
Verastem Oncology
Verastem Oncology
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
Tanvex BioPharma
Tanvex BioPharma
Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Relay Therapeutics
Relay Therapeutics
Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.
Mirati Therapeutics
Mirati Therapeutics
Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.
InxMed
InxMed
InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines.
Founding Date
Founding Date
2010
Founding Date
2013
Founding Date
1996
Founding Date
2016
Founding Date
2013
Founding Date
2018
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Subsidiary
Type
Private
Tags
Locations
Locations
Needham, US HQ
Walsrode, DE
Locations
Taipei, TW HQ
New Taipei, TW
Irvine, US
San Diego, US
San Diego, US
Locations
Basel, CH HQ
Tirana, AL
Buenos Aires, AR
Macquarie Park, AU
Kundl, AT
Unterlangkampfen, AT
Wien, AT
see more
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Zug, CH
Locations
HQ
Employees
Employees
5719% increase
Employees
18910% increase
Employees
76,057
Employees
3211% decrease
Employees
2884% decrease
Employees
17
Twitter followers
Twitter followers
2.6 k
Twitter followers
N/A
Twitter followers
301.8 k
Twitter followers
N/A
Twitter followers
1.3 k
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
4
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
15
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
8.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
75%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
93.33%
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$54.1b (FY, 2023)
Revenue (est.)
$25.5m (FY, 2023)
Revenue (est.)
$12.4m (FY, 2022)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$8.2b (FY, 2023)
Cost of goods
N/A
Cost of goods
$600k (FY, 2022)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$47.7b (FY, 2023)
Gross profit
N/A
Gross profit
$11.8m (FY, 2022)
Gross profit
N/A
Net income
Net income
($87.4m) (FY, 2023)
Net income
N/A
Net income
$9b (FY, 2023)
Net income
($342m) (FY, 2023)
Net income
($740.9m) (FY, 2022)
Net income
N/A

Operating

Phase I/II Trials Products
Phase I/II Trials Products
6 (FY, 2020)
Phase I/II Trials Products
N/A
Phase I/II Trials Products
100 (FY, 2022)
Phase I/II Trials Products
N/A
Phase I/II Trials Products
N/A
Phase I/II Trials Products
N/A

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 400m (over 5 years ago)
Latest funding round
N/A
Latest funding round
$ 19m (over 3 years ago)
Total funding raised
Total funding raised
$ 170m
Total funding raised
$ 346.9m
Total funding raised
$ 6.5m
Total funding raised
$ 520m
Total funding raised
N/A
Total funding raised
$ 19m
For sources of this data, please see the company profile

View Company Profiles

Tanvex BioPharma
HQ
Taipei, TW
Employees
189↑ 10% increase

Tanvex BioPharma (formerly known as Ruenvex Biotech) is a company that manufactures and develops biosimilar and biologic products and drugs.

View company
Novartis
HQ
Basel, CH
Employees
76,057

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company
Relay Therapeutics
HQ
Cambridge, US
Employees
321↓ 1% decrease

Relay Therapeutics was founded on the premise that putting protein motion at the heart of drug discovery can dramatically expand therapeutic possibilities.

View company
Mirati Therapeutics
HQ
San Diego, US

Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.

View company